BioAlliance Pharma’s Innovation Rewarded

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced that Dominique Costantini MD (President of the company’s Executive Board) has won the Engineer of the Year Award in entrepreneurship category.

MORE ON THIS TOPIC